LivaNova PLC (NASDAQ:LIVN) Shares Sold by Lighthouse Investment Partners LLC

Lighthouse Investment Partners LLC decreased its holdings in LivaNova PLC (NASDAQ:LIVN) by 23.9% in the second quarter, Holdings Channel reports. The firm owned 41,000 shares of the company’s stock after selling 12,876 shares during the period. Lighthouse Investment Partners LLC’s holdings in LivaNova were worth $2,248,000 as of its most recent SEC filing.

Several other institutional investors and hedge funds have also recently added to or reduced their stakes in LIVN. Point72 Asset Management L.P. raised its stake in LivaNova by 204.3% in the second quarter. Point72 Asset Management L.P. now owns 1,285,636 shares of the company’s stock valued at $70,479,000 after buying an additional 863,157 shares during the last quarter. First Light Asset Management LLC raised its position in shares of LivaNova by 591.1% in the 2nd quarter. First Light Asset Management LLC now owns 710,390 shares of the company’s stock valued at $38,944,000 after purchasing an additional 607,598 shares during the last quarter. Norges Bank acquired a new stake in LivaNova in the 4th quarter worth approximately $26,064,000. Great Lakes Advisors LLC acquired a new stake in LivaNova in the 2nd quarter worth approximately $16,614,000. Finally, Mesirow Institutional Investment Management Inc. purchased a new stake in LivaNova during the 1st quarter worth approximately $13,816,000. 97.64% of the stock is currently owned by hedge funds and other institutional investors.

Analyst Ratings Changes

Several research firms have recently commented on LIVN. Baird R W upgraded shares of LivaNova from a “hold” rating to a “strong-buy” rating in a research note on Tuesday, September 17th. Stifel Nicolaus lifted their price target on LivaNova from $70.00 to $72.00 and gave the stock a “buy” rating in a research report on Thursday, July 25th. Needham & Company LLC boosted their price target on LivaNova from $72.00 to $75.00 and gave the company a “buy” rating in a research note on Wednesday, July 31st. Finally, Robert W. Baird raised shares of LivaNova from a “neutral” rating to an “outperform” rating and raised their price target for the stock from $55.00 to $66.00 in a research report on Tuesday, September 17th. One equities research analyst has rated the stock with a hold rating, five have issued a buy rating and one has given a strong buy rating to the stock. According to MarketBeat, LivaNova currently has a consensus rating of “Buy” and an average price target of $70.80.

LivaNova Stock Up 0.4 %

Shares of LIVN opened at $52.52 on Friday. The company has a market capitalization of $2.84 billion, a price-to-earnings ratio of -87.53 and a beta of 1.00. LivaNova PLC has a 52 week low of $42.75 and a 52 week high of $64.47. The stock’s 50-day moving average price is $48.71 and its 200-day moving average price is $53.33. The company has a quick ratio of 2.94, a current ratio of 3.45 and a debt-to-equity ratio of 0.49.

LivaNova (NASDAQ:LIVN) last released its quarterly earnings data on Wednesday, July 31st. The company reported $0.81 EPS for the quarter, topping the consensus estimate of $0.66 by $0.15. The business had revenue of $318.60 million for the quarter, compared to analyst estimates of $305.05 million. LivaNova had a positive return on equity of 13.77% and a negative net margin of 1.37%. On average, sell-side analysts predict that LivaNova PLC will post 2.58 EPS for the current year.

LivaNova Company Profile

LivaNova PLC, a medical device company, designs, develops, manufactures, and sells therapeutic solutions worldwide. The company operates through Cardiopulmonary, Neuromodulation, and Advanced Circulatory Support segments. The Cardiopulmonary segment develops, produces, and sells cardiopulmonary products, including oxygenators, heart-lung machines, autotransfusion systems, perfusion tubing systems, cannulae, connect, and other related products.